Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Palmer SC, Tendal B, Mustafa RA, et al.
BMJ 2021;372:m4573
Leggi